Evidence map›Paper›PMID 22139962›Full record

ReviewGenesis (New York, N.Y. : 2000)2012

The epigenome in early vertebrate development.

Ozren Bogdanović, Simon J van Heeringen, Gert Jan C Veenstra

Abstract readReview
In one paragraph

Review in Genesis (New York, N.Y. : 2000), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Genomic Profiling of Chromatin State Using CUT&Tag.Methods in molecular biology (Clifton, N.J.) · 2027
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Establishing pluripotency in early development.Biochimica et biophysica acta · 2015
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ozren BogdanovićDepartment of Molecular Biology, Faculty of Science, Nijmegen Centre of Molecular Life Sciences, Radboud University Nijmegen, Nijmegen, The Netherlands.
Simon J van Heeringen
Gert Jan C Veenstra

Funding

Interrogating the Xenopus tropicalis genome using tile path microarraysR01HD054356 · NICHD · STICHTING RADBOUD UNIVERSITEIT · PI VEENSTRA, GERT JAN C. · 2007 to 2011
$1.1M
NICHD NIH HHS 5R01HD054356NICHD NIH HHS R01 HD054356
6 · The paper itself

Abstract

Epigenetic regulation defines the commitment and potential of cells, including the limitations in their competence to respond to inducing signals. This review discusses the developmental origins of chromatin state in Xenopus and other vertebrate species and provides an overview of its use in genome annotation. In most metazoans the embryonic genome is transcriptionally quiescent after fertilization. This involves nucleosome-dense chromatin, repressors and a temporal deficiency in the transcription machinery. Active histone modifications such as H3K4me3 appear in pluripotent blastula embryos, whereas repressive marks such as H3K27me3 show a major increase in enrichment during late blastula and gastrula stages. The H3K27me3 modification set by Polycomb restricts ectopic lineage-specific gene expression. Pluripotent chromatin in Xenopus embryos is relatively unconstrained, whereas the pluripotent cell lineage in mammalian embryos harbors a more enforced type of pluripotent chromatin.

Indexed as

Epigenesis, GeneticAnimalsBlastulaChromatinEmbryonic DevelopmentHistonesModels, GeneticMolecular Sequence AnnotationPolycomb-Group ProteinsRepressor ProteinsVertebratesChromatinHistonesPolycomb-Group ProteinsRepressor Proteins

Identifiers

PMID22139962
PMCPMC3294079

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.